Clinical Trial Update: Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated amifostine for treating paclitaxel-induced peripheral neuropathy in patients with solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Peripheral Neuropathy
• Prostate Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: COMPLETED